“Axillary Hyperhidrosis HDSM-Ax-7 Patient-Reported Outcomes for Sofpironium Topical Gel,12.45%: A Multicenter, Randomized, Controlled Double-Blind Study (NCT03836287)”. 2025. SKIN The Journal of Cutaneous Medicine 9 (4): s588. https://doi.org/10.25251/yvdyat28.